Quest Diagnostics Incorporated company logo

# 1st Gen Model Quest Diagnostics Incorporated Medical laboratories

66.67% successful of 81 deals
$95.08 Last close price
at 20-oct-2017
  • Top 20 Accuracy

DGX

Model's trade recommendations -10.65% Return for period

-0.75% Annual return

$12.56B Market Cap

β 0.65  

DGX

Model (following trade recommendations)

DGX

Underlying stock

S&P 500

Index
Return for period -10.65%
0.54%
1.78%
52wk return -11.22%
13.61%
16.82%
52wk Range
79.93—111.16
2000.54—2399.63
Sortino ratio -0.09
Sharpe ratio -0.08
Norm. RMSE 0.96%
Downside risk 7.64%
Volatility 8.87%
  • 1.80 (1.96%) Div (Yield)
  • HOLD Analysts consensus recommendation

Quest Diagnostics Inc., is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care.

Industry sector: Medical

Sector classification: Medical laboratories

Deep Learning based analysis and prediction model for Quest Diagnostics Incorporated (DGX) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 22, 2015.

Market data for DGX model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 134M
P/E 16.56
Shares Outstanding 136M
% Held by Insiders 1.75%
% Held by Institutions 86.99%
EPS (last reported FY) $5.15
EPS (last reported Q) $1.55
EPS, estimated (last reported Q) $1.41
Total revenues $8 B
Net income $1 B